Akuttherapie des Schlaganfalls

Lernziele

In dieser Übersichtsarbeit wird neben der Vermittlung von epidemiologischen Aspekten auf den besonderen Stellenwert der Prähospitalphase eingegangen. Weiter werden die wesentlichen Stützpfeiler der Stroke-Unit-Behandlung beschrieben. Ein besonderer Schwerpunkt wird auf die Stroke-Unit-Behandlung im derzeitigen DRG-System gelegt (DRG = Diagnosis related Groups). Im Weiteren werden in dieser Arbeit neben neuen Entwicklungen in der Bildgebung die aktuellen Therapieverfahren zur Akutbehandlung des Schlaganfalls, die zuletzt veröffentlichten negativen Studien sowie die derzeit laufenden Studien beschrieben.

Literatur

• 1 Adams Jr H P, Bendixen B H, Kappelle L J. et al . Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10 172 in Acute Stroke Treatment.  Stroke. 1993;  24 35-41
• 2 Rothwell P M, Giles M F, Flossmann E. et al . A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack.  Lancet. 2005;  366 29-36
• 3 Rothwell P M, Coull A J, Silver L E. et al . Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study).  Lancet. 2005;  366 1773-1783
• 4 Candelise L, Gattinoni M, Bersano A. et al . Stroke-unit care for acute stroke patients: an observational follow-up study.  Lancet. 2007;  369 299-305
• 5 Govan L, Langhorne P, Weir C J. Does the prevention of complications explain the survival benefit of organized inpatient (stroke unit) care?: further analysis of a systematic review.  Stroke. 2007;  38 2536-2540
• 6 Indredavik B, Slordahl S A, Bakke F. et al . Stroke unit treatment. Long-term effects.  Stroke. 1997;  28 1861-1866
• 7 Indredavik B, Bakke F, Slordahl S A. et al . Stroke unit treatment. 10-year follow-up.  Stroke. 1999;  30 1524-1527
• 8 Sherman D G, Albers G W, Bladin C. et al . The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.  Lancet. 2007;  369 1347-1355
• 9 Hacke W, Donnan G, Fieschi C. et al . Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.  Lancet. 2004;  363 768-774
• 10 Wahlgren N, Ahmed N, Davalos A. et al . Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.  Lancet. 2007;  369 275-282
• 11 Lindsberg P J, Mattle H P. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis.  Stroke. 2006;  37 922-928
• 12 Smith W S, Sung G, Saver J. et al . Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial.  Stroke. 2008;  39 1205-1212
• 13 Schulte-Altedorneburg G, Mayer T E. Management of acute basilar artery occlusion.  Radiologe. 2007;  47 355-335
• 14 Schellinger P D, Thomalla G, Fiehler J. et al . MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients.  Stroke. 2007;  38 2640-2645
• 15 Thomalla G, Schwark C, Sobesky J. et al . Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials.  Stroke. 2006;  37 852-858
• 16 Davis S M, Donnan G A, Parsons M W. et al . Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.  Lancet Neurol. 2008;  7 299-309
• 17 Vahedi K, Hofmeijer J, Juettler E. et al . Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials.  Lancet Neurol. 2007;  6 215-222
• 18 Shuaib A, Lees K R, Lyden P. et al . NXY-059 for the treatment of acute ischemic stroke.  N Engl J Med. 2007;  357 562-571
• 19 Diener H C, Lees K R, Lyden P. et al . NXY-059 for the Treatment of Acute Stroke. Pooled Analysis of the SAINT I and II Trials.  Stroke. 2008; 
• 20 Adams Jr H P, Effron M B, Torner J. et al . Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).  Stroke. 2008;  39 87-99
• 21 Mendelow A D, Gregson B A, Fernandes H M. et al . Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial.  Lancet. 2005;  365 387-397